First Time Loading...

Northeast Pharmaceutical Group Co Ltd
SZSE:000597

Watchlist Manager
Northeast Pharmaceutical Group Co Ltd Logo
Northeast Pharmaceutical Group Co Ltd
SZSE:000597
Watchlist
Price: 4.81 CNY -2.24% Market Closed
Updated: May 16, 2024

Northeast Pharmaceutical Group Co Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Northeast Pharmaceutical Group Co Ltd
Interest Income Expense Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Northeast Pharmaceutical Group Co Ltd
SZSE:000597
Interest Income Expense
¥84.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Interest Income Expense
¥1.1B
CAGR 3-Years
52%
CAGR 5-Years
82%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Interest Income Expense
¥134.5m
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
23%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Interest Income Expense
¥429.9m
CAGR 3-Years
-8%
CAGR 5-Years
4%
CAGR 10-Years
30%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Interest Income Expense
¥1.1B
CAGR 3-Years
-16%
CAGR 5-Years
-11%
CAGR 10-Years
37%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Interest Income Expense
¥115.4m
CAGR 3-Years
102%
CAGR 5-Years
98%
CAGR 10-Years
N/A

See Also

What is Northeast Pharmaceutical Group Co Ltd's Interest Income Expense?
Interest Income Expense
84.8m CNY

Based on the financial report for Dec 31, 2023, Northeast Pharmaceutical Group Co Ltd's Interest Income Expense amounts to 84.8m CNY.

What is Northeast Pharmaceutical Group Co Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 1Y
179%

Over the last year, the Interest Income Expense growth was 179%.